YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Event to Feature Digit 5, Agility's Scaling Strategy and Perspectives From Schaeffler, Foxconn and AUVSI SALEM, Ore., October 06, 2026--(BUSINESS WIRE)--Agility Robotics, a leading humanoid robotics and physical AI company, will host its A…
New Offboard Safety Bridge Extends Agility and FORT's Safety Architecture to Digit 5 SALEM, Ore. and PHILADELPHIA, Oct. 1, 2026 /PRNewswire/ -- Agility Robotics, a leading humanoid robotics and physical AI company, and FORT Robotics, a saf…
[Headquarters of SpaceX in Hawthorne, California] Sven Piper Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Shares of Churchill Capital Corp XI are trading higher Monday morning following last week's announcement of a definitive business combinat…
Agility Robotics, a US-based humanoid robotics company, has entered into a definitive agreement to merge with Churchill Capital Corp XI, a publicly traded special purpose acquisition company (SPAC). The business combination values Agility…
The humanoid robot startup Agility Robotics is going public at a $2.5 billion valuation via a SPAC merger with Churchill Capital. Shares of Churchill Capital initially soared nearly 30% on Wednesday morning. Continue Reading
A rising player in robotics is slated to go public later this year and will become the first pure play on humanoid robots to trade on the U.S. market. Agility Robotics has agreed to merge with Churchill Capital Corp XI a publicly traded bl…
Agility Robotics announced a merger agreement with Churchill Capital Corp XI on Wednesday that values the humanoid robotics company at $2.5 billion and is expected to take it public on a major North American exchange under the ticker symbo…
A rising player in robotics is slated to go public later this year and will become the first pure play on humanoid robots to trade on the U.S. market. Agility Robotics has agreed to merge with Churchill Capital Corp XI a publicly traded bl…
* Agility Robotics and Churchill Capital (CCXI [https://seekingalpha.com/symbol/CCXI]) have entered into a definitive business combination agreement, the companies said on Wednesday. Upon closing of the transaction, the combined company is…
Transaction expected to create the only U.S. publicly listed pure-play humanoid company with proven, active commercial deployments Operating today in commercial environments with leading enterprises including Schaeffler, GXO, Toyota Motor…
June 24 (Reuters) - Agility Robotics will go public via a merger with Churchill Capital Corp XI, valuing the startup at about $2.5 billion, the Wall Street Journal reported on Wednesday, citing the company's executives. Here are some de…
What happened According to a February 9, 2026, SEC filing, MMCAP International Inc. SPC increased its position in NexGen Energy Ltd.(NYSE:NXE) by 2,379,891 shares during the fourth quarter of 2025. The estimated transaction value was appro…
New York, NY, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XI (Nasdaq: CCXIU) (the “Company”) announced today that, commencing February 9, 2026, holders of the units sold in the Company’s initial public offering may elect to se…
Investing.com - Stifel maintained its Buy rating and $36.00 price target on Avalo Therapeutics Inc. (NASDAQ:AVTX), representing significant upside from the current price of $6.73, following a virtual non-deal roadshow with the company’s ma…
Amgen Inc (NASDAQ: AMGN) has agreed to buy Horizon Therapeutics plc (NASDAQ: HZNP), implying an enterprise value of approximately $28.3 billion, marking the largest healthcare merger of the year. The Wall Street Journal was the first to re…
TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., Oct. 20, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it ha…
ChemoCentryx, Inc. -- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS® (avacopan) for patients with ANCA-associated vasculitis; additional poster will cover expression of…
-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS® (avacopan) for patients with ANCA-associated vasculitis; additional poster will cover expression of kidney C5aR -- SAN…
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has ChemoCentryx (CCXI) been one of those stocks this year? Let's take a closer look at the stock's yea…
ChemoCentryx, Inc. -- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN CARLOS, Calif., Oct. 05, 202…
-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN CARLOS, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE)…
It has been about a month since the last earnings report for Ionis Pharmaceuticals (IONS). Shares have lost about 5.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings…
A month has gone by since the last earnings report for ChemoCentryx (CCXI). Shares have added about 1.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is…
Today I’m writing about Dow stocks to buy. Seasoned investors are realizing that many of the 30 members of the Dow Jones Industrial Average (DJIA) are now trading at low valuation levels and prices. The index serves as a bellwether that tr…
While investors look for safe bets, here are seven Dow stocks to buy in September.
Ultimately, Amgen agreed to pay a price $8 per share larger than its nearest competitor for a 25-year-old company with one FDA-approved drug.
Biotech stocks are scorching right now. But the best of the best have strong gains. Those include 10 with at least 40% growth this year.
ChemoCentryx, Inc. SAN CARLOS, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned poster presentations at three upcoming medical conferences taking place in August and September, which hig…
SAN CARLOS, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned poster presentations at three upcoming medical conferences taking place in August and September, which highlight TAVNEOS® (av…
NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders…
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following…
After reaching an important support level, ChemoCentryx, Inc. (CCXI) could be a good stock pick from a technical perspective. CCXI recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above i…
Rating Action: Moody's assigns Baa1 rating to Amgen's notes; stable outlookGlobal Credit Research - 15 Aug 2022New York, August 15, 2022 -- Moody's Investors Service ("Moody's") assigned a Baa1 rating to the new senior unsecured notes offe…
For Immediate Release Chicago, IL – August 12, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial m…
ChemoCentryx, Inc. SAN CARLOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of its second quarter 2022 financial results conference call scheduled for Tuesday, August 9, 202…